Edwards Lifesciences (EW) PT Lowered to $99 at Citi
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as climbing oil, yields amplify inflation fears
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $82.86 -3.4%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 34
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 34
Join SI Premium – FREE
Citi analyst Joanna Wuensch lowered the price target on Edwards Lifesciences (NYSE: EW) to $99.00 (from $107.00) while maintaining a Buy rating.
You May Also Be Interested In
- UBS Reiterates Buy Rating on Edwards Lifesciences (EW)
- Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
- ArcBest Corp (ARCB) PT Lowered to $168 at Stifel, Buy Rating Maintained on 'Sound Financial Footing'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
